Virtual reality iliac angioplasty simulator introduction planned for December RSNA meeting.
This article was originally published in The Gray Sheet
Executive SummaryVIRTUAL REALITY ILIAC ANGIOPLASTY SIMULATOR NEARING COMPLETION, according to Massachusetts General Hospital developers Steve Dawson, MD, and John Kaufman, PhD. The simulator, intended for use in medical training, provides visual and tactile feedback to catheter and guidewire manipulations. The researchers plan to unveil the device at the Dec. 1-6 meeting of the Radiological Society of North America in Chicago, but may have it ready for the 3rd International Symposium on Cardiovascular and Interventional Radiology to be held Oct. 8-11 in Boston.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.